Resmed Inc. buy Royal Bank of Canada
Start price
15.07.25
/
50%
€220.80
Target price
15.07.26
€251.96
Performance (%)
-3.49%
Price
16:30
€213.10
Summary
This prediction is currently active. With a performance of -3.49%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 15.07.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -0.874% | -0.874% |
| iShares Core DAX® | -1.410% | 0.471% |
| iShares Nasdaq 100 | -0.450% | -0.305% |
| iShares Nikkei 225® | -0.224% | 5.529% |
| iShares S&P 500 | -1.095% | -0.774% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $294.00 price target on the stock.
Ratings data for RMD provided by MarketBeat